CDSCO-Approved Treatment

tDCS Brain Stimulation.

How it works and why it's safe.

ease Headset
63.8%
Depression symptom\nreduction (AIIMS Delhi)
200+
Peer-reviewed\nstudies
20 min
Non-invasive\nsessions
Class B
CDSCO certified\nmedical device
01 · INTRODUCTION

What is tDCS?

The Layman Explanation

Imagine your brain as a city with an electrical grid. Some neighbourhoods like the prefrontal cortex, which governs mood and decision-making have been running on reduced power. Depression, anxiety, ADHD, and addiction all involve specific areas of this grid becoming underactive.

tDCS delivers a very small, steady electrical current typically 1 to 2 milliamperes (the kind of current a AA battery produces at rest) through two electrodes on your scalp. This current gently increases the excitability of neurons under the positive electrode (the anode), making them more ready to fire. Over a series of sessions, this persistent nudge helps restore healthy activity patterns and rebuild the neural connections that support emotional regulation, attention, and cognitive control.

01

Tiny current

1–2 mA through scalp electrodes — about what a resting AA battery produces.

02

Targeted nudge

The anode raises neuron excitability in the underactive brain region.

03

Network repair

Repeated sessions rebuild the neural connections that regulate mood and attention.

02 · IN-SESSION

What Happens to your Brain During a 20-Minute Session

When you put on the ease headset and begin a session:

1

A low-amplitude current flows from the anode electrode (positioned over the target brain region) through your skull and into the cortex

2

Neurons under the anode become more excitable their membrane potential shifts closer to the threshold needed to fire

3

This increased excitability persists for a period after the session ends, thanks to a process called long-term potentiation the same mechanism underlying learning and memory

4

Simultaneously, the CET exercises in the ease app activate the same circuits being stimulated, directing the neuroplastic changes towards specific functional improvements

5

The EEG sensors monitor how your brain is responding throughout, giving your doctor real-time data

You may feel a mild tingling or warmth at the electrode sites during the session. This is normal, temporary, and harmless.

03 · COMPARISON

tDCS vs Other Brain Stimulation Techniques

ATTRIBUTEtDCS (ease)rTMSECT
Current strength1–2 mA (gentle)Magnetic pulses~400× stronger than tDCS
AnaesthesiaNoneNoneRequired
WhereAt home or clinicClinic onlyHospital only
SensationMild tinglingClicking sound, loudInduces seizure
EEG monitoringReal-time, integratedNot integratedNot integrated
Cognitive trainingBuilt-in (CET)Not integratedNot integrated

tDCS vs ECT — not even the same category

Electroconvulsive therapy (ECT) uses currents hundreds of times stronger than tDCS, induces a generalised seizure under anaesthesia, and requires hospital administration. tDCS uses a current 400 times weaker than ECT, induces no seizure, requires no anaesthesia, and can be administered at home. The two are not comparable tDCS is to ECT what a gentle massage is to surgery.

tDCS vs rTMS (TMS)

Repetitive Transcranial Magnetic Stimulation (rTMS) uses magnetic pulses to stimulate the brain and is effective for depression and OCD. rTMS requires clinic visits for every session, is louder (the device makes a clicking sound), and does not integrate real-time EEG monitoring or cognitive training. tDCS is quieter, more portable, and in ease's case, uniquely combined with EEG and CET for a more comprehensive intervention.

04 · EVIDENCE

200+ Peer-Reviewed Studies

The Evidence Base

tDCS is not experimental. It has accumulated over 200 peer-reviewed studies across depression, anxiety, OCD, ADHD, addiction, stroke rehabilitation, chronic pain, and cognitive enhancement. Key landmarks include:

63.8%
Reduction in depression\nsymptoms
AIIMS DELHI VALIDATION
84%
Remission with the ease\ntDCS + CET protocol
AIIMS DELHI VALIDATION
33.3%
Active tDCS response rate\nvs 16.56% sham
RAZZA ET AL. 2020 META-ANALYSIS

Key landmark studies

2017

NEJM (Brunoni et al.)

tDCS found significantly more effective than placebo in a 10-week double-blind RCT for depression

2020

Razza et al. Meta-Analysis

Meta-analysis of 23 RCTs showed active tDCS demonstrating 33.3% vs 16.56% response rate over sham

2024

Molecular Psychiatry Umbrella Review

GRADE=high evidence for tDCS in OCD; strong evidence across multiple conditions

AIIMS

Delhi Validation Study

63.8% reduction in depression symptoms, 84% remission with the specific ease tDCS + CET protocol

05 · SAFETY

Is tDCS Safe?

Side Effects, Contraindications, Tolerability

tDCS has an excellent safety profile. In clinical trials and real-world use across tens of thousands of patients, the side effects are consistently mild and temporary:

MILD & TEMPORARY

Reported side effects

  • Mild tingling or itching at the electrode site during the session reported by most users, resolves immediately after
  • Mild headache, reported by a small minority, typically after the first few sessions, resolves within hours
  • Temporary skin redness under the electrodes, harmless and fades within minutes

Serious adverse events have not been reported in clinical trial data for standard tDCS protocols at 1–2 mA. There are no systemic side effects because the current does not enter the bloodstream.

CONTRAINDICATIONS

Not suitable if you have

  • Metal implants in the head
  • Cochlear implants
  • Active epilepsy or history of seizures
  • Certain implanted devices (pacemakers)
  • Skin conditions affecting the scalp in the electrode area

Always consult your doctor before starting treatment.

06 · REGULATION

CDSCO Class B Approval

What It Means for Indian Patients

CLASSBCDSCO

First and only CDSCO Class B device for tDCS in India.

CDSCO is India's Central Drugs Standard Control Organisation, the regulatory body that approves medical devices for sale and clinical use in India. Class B is the category for moderate-risk medical devices. ease is the first and only device in India to receive CDSCO Class B approval for tDCS-based neuropsychiatric treatment.

This matters. It means ease has passed independent safety and efficacy review by India's top medical regulator. When your doctor prescribes ease, they are prescribing a certified medical device, not a consumer gadget.

Ready to see if ease is right for you?

Book a consultation with a Marbles-trained doctor near you.